Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Tongren Tang Pharmaceutical Industry is a historic Chinese pharmaceutical company specializing in the production and distribution of Traditional Chinese Medicine (TCM). Established in 1926 as a branch of the original Tong Ren Tang, it has evolved into an independent entity known for modernizing ancient prescriptions into various dosage forms like pills, capsules, and granules. The company's extensive product line covers therapeutic areas such as cardiology, gastroenterology, and gynecology, with flagship products like Angong Niuhuang Wan and Wuji Baifeng Wan. Operating large-scale GMP-certified facilities, Nanjing Tongren Tang integrates traditional heritage with modern manufacturing technology to serve the domestic and international healthcare markets. The company is recognized as a "China Time-honored Brand" (Zhonghua Lao Zi Hao) and maintains a significant presence in the retail and hospital sectors across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Tongren Tang Pharmaceutical Industry.